BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 36353214)

  • 1. CD93 negatively regulates astrogenesis in response to MMRN2 through the transcriptional repressor ZFP503 in the developing brain.
    Liang Q; Su L; Zhang D; Jiao J
    Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9413-9422. PubMed ID: 32291340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound Imaging of Tumor Vascular CD93 with MMRN2 Modified Microbubbles for Immune Microenvironment Prediction.
    Wang D; Xing C; Liang Y; Wang C; Zhao P; Liang X; Li Q; Yuan L
    Adv Mater; 2024 May; 36(18):e2310421. PubMed ID: 38270289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insight into CD93 recognition by IGFBP7.
    Xu Y; Sun Y; Zhu Y; Song G
    bioRxiv; 2023 Jun; ():. PubMed ID: 37333140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the CD93 pathway normalizes tumor vasculature to facilitate drug delivery and immunotherapy.
    Sun Y; Chen W; Torphy RJ; Yao S; Zhu G; Lin R; Lugano R; Miller EN; Fujiwara Y; Bian L; Zheng L; Anand S; Gao F; Zhang W; Ferrara SE; Goodspeed AE; Dimberg A; Wang XJ; Edil BH; Barnett CC; Schulick RD; Chen L; Zhu Y
    Sci Transl Med; 2021 Jul; 13(604):. PubMed ID: 34321321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insight into CD93 recognition by IGFBP7.
    Xu Y; Sun Y; Zhu Y; Song G
    Structure; 2024 Mar; 32(3):282-291.e4. PubMed ID: 38218180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress of CD93
    Niu C; Sun S; Liu D
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):267-272. PubMed ID: 38512037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of CD93 in Health and Disease.
    Tossetta G; Piani F; Borghi C; Marzioni D
    Cells; 2023 Jul; 12(13):. PubMed ID: 37443812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dimerization of the C-type lectin-like receptor CD93 promotes its binding to Multimerin-2 in endothelial cells.
    Barbera S; Raucci L; Tassone G; Tinti L; Prischi F; Santucci A; Mongiat M; Tosi GM; Galvagni F; Dimberg A; Pozzi C; Orlandini M
    Int J Biol Macromol; 2023 Jan; 224():453-464. PubMed ID: 36265539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-type lectin domain group 14 proteins in vascular biology, cancer and inflammation.
    Khan KA; McMurray JL; Mohammed F; Bicknell R
    FEBS J; 2019 Sep; 286(17):3299-3332. PubMed ID: 31287944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics Approaches to Predict Mutation Effects in the Binding Site of the Proangiogenic Molecule CD93.
    Cicaloni V; Karmakar M; Frusciante L; Pettini F; Visibelli A; Orlandini M; Galvagni F; Mongiat M; Silk M; Nardi F; Ascher D; Santucci A; Spiga O
    Front Bioinform; 2022; 2():891553. PubMed ID: 36353214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium.
    Galvagni F; Nardi F; Spiga O; Trezza A; Tarticchio G; Pellicani R; Andreuzzi E; Caldi E; Toti P; Tosi GM; Santucci A; Iozzo RV; Mongiat M; Orlandini M
    Matrix Biol; 2017 Dec; 64():112-127. PubMed ID: 28912033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.
    Khan KA; Naylor AJ; Khan A; Noy PJ; Mambretti M; Lodhia P; Athwal J; Korzystka A; Buckley CD; Willcox BE; Mohammed F; Bicknell R
    Oncogene; 2017 Nov; 36(44):6097-6108. PubMed ID: 28671670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis modulated by CD93 and its natural ligands IGFBP7 and MMRN2: a new target to facilitate solid tumor therapy by vasculature normalization.
    Li Y; Fu L; Wu B; Guo X; Shi Y; Lv C; Yu Y; Zhang Y; Liang Z; Zhong C; Han S; Xu F; Tian Y
    Cancer Cell Int; 2023 Sep; 23(1):189. PubMed ID: 37660019
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.